InferRead DR Tuberculosis
Infervision
Information source:
Public
Last updated: November 6, 2024 |
General Information
General | |
---|---|
Product name | InferRead DR Tuberculosis |
Company | Infervision |
Subspeciality | Chest |
Modality | X-ray |
Disease targeted | Tuberculosis |
Key-features | Tuberculosis detection |
Suggested use |
Technical Specifications
Data characteristics | |
---|---|
Population | |
Input | |
Input format | |
Output | |
Output format | |
Technology | |
Integration | |
Deployment | |
Trigger for analysis | |
Processing time |
Regulatory
Certification | |
---|---|
CE |
Certified,
Class IIb
, MDR
|
FDA | No or not yet |
Intended Use Statements | |
Intended use (according to CE) | The design, Development and Manufacture of Computer aided diagnostic software for viewing and analyzing DICOM images to assist physicians with abnormality detection and diagnosis. |
Market
Market presence | |
---|---|
On market since | 01-2020 |
Distribution channels | Stop TB Partnership Global Drug Facility |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | |
Based on |
Evidence
Evidence | |
---|---|
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |